Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zentalis Pharmaceuticals Inc
NASDAQ:ZNTL
|
US |
|
Hecla Mining Co
NYSE:HL
|
US |
|
MSCI Inc
NYSE:MSCI
|
US |
|
Hong Kong Exchanges and Clearing Ltd
HKEX:388
|
HK |
|
C
|
Chayo Group PCL
SET:CHAYO
|
TH |
|
C
|
Canadian Natural Resources Ltd
NYSE:CNQ
|
CA |
|
KDX Realty Investment Corp
OTC:KDXRF
|
JP |
|
ServisFirst Bancshares Inc
NYSE:SFBS
|
US |
|
C
|
ChipMOS Technologies Inc
TWSE:8150
|
TW |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
ID |
|
A
|
Aurubis AG
XETRA:NDA
|
DE |
|
Naver Corp
KRX:035420
|
KR |
|
Aeon Co Ltd
TSE:8267
|
JP |
|
Mondelez International Inc
NASDAQ:MDLZ
|
US |
|
Marsh & McLennan Companies Inc
NYSE:MMC
|
US |
|
Agricultural Bank of China Ltd
SSE:601288
|
CN |
|
Air China Ltd
SSE:601111
|
CN |
|
CGI Inc
TSX:GIB.A
|
CA |
|
Stride Inc
NYSE:LRN
|
US |
|
PAR Technology Corp
NYSE:PAR
|
US |
|
L
|
Lockheed Martin Corp
XETRA:LOM
|
US |
Wall St Price Targets
ZNTL Price Targets Summary
Zentalis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ZNTL is 6.38 USD with a low forecast of 2.02 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZNTL's stock price target?
Price Target
6.38
USD
According to Wall Street analysts, the average 1-year price target for
ZNTL is 6.38 USD with a low forecast of 2.02 USD and a high forecast of 10.5 USD.